 "Biocon")
Biocon Biologics has elevated deputy CEO Shreehas Tambe as its Managing Director and CEO effective Monday, the company said.
Tambe takes over from Arun Chandavarkar, who will continue as non-executive, non-independent director on the firm's board.
Tambe has been with Biocon since 1997, and has helped shape and build its biosimilars business and spearheaded the group’s strategic capital investments, including its first overseas facility in Malaysia.
“He has also been instrumental in securing regulatory approvals and enabling the successful launch of several of the company’s biosimilar assets in global markets such as the US and EU,” the company said.
Kiran
